Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for Telmisartan submitted by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan (Telmisartan)

Snippet

SUPPL AP for TELMISARTAN (TELMISARTAN)